A Look At Burford Capital (BUR) Valuation After US Court Pause In $18b YPF Asset Tracing
Burford Capital Limited BUR | 0.00 |
Burford Capital (NYSE:BUR) stock came under pressure after a US appeals court temporarily paused asset tracing in the US$18 billion YPF litigation. This move introduces fresh uncertainty around the timing and collection of this key award.
The stock's 1 day share price return of 9.37% and 7 day share price return of 3.55% come after a much tougher spell, with the 90 day share price return down 52.10% and the 1 year total shareholder return down 64.00%. This suggests that recent legal setbacks have sharply shifted how the market prices Burford's risk and recovery prospects.
If this kind of volatility has you looking wider, it could be a good moment to scan for other opportunities using our 20 top founder-led companies
With Burford now trading at US$4.67 after steep 1 year and multi year share price declines, yet sitting at a reported 46% intrinsic discount, you have to ask: is this legal finance stock mispriced, or is the market already factoring in all the future upside?
Most Popular Narrative: 47.7% Undervalued
Against a last close of $4.67, the most followed narrative anchors Burford Capital's fair value at about $8.94, creating a wide valuation gap that hinges heavily on future case outcomes and cash flows.
Platform diversification across geographies, legal verticals, and risk/duration characteristics is translating into a more robust, less volatile portfolio with greater ability to consistently realize gains and improve risk-adjusted earnings.
Read the complete narrative. Read the complete narrative.
Curious what is driving that gap between price and narrative value? The core of this story rests on expectations for steep revenue expansion, sharply higher margins, and a profit profile that could look very different from today. The numbers behind those assumptions are what really matter.
Result: Fair Value of $8.94 (UNDERVALUED)
However, this depends on the YPF case not stalling further and on regulators not tightening rules around litigation funding in key markets.
Another Angle on Valuation
The first narrative leans heavily on future cash flows and case wins, but current market ratios tell a more mixed story. Burford is described as trading at a P/B of 1.2x, which is in line with the US Diversified Financial industry at 1.2x, yet well below a 19.1x peer average. That gap hints at either a valuation opportunity or a clear warning that peers are very different businesses. Which side of that trade do you think you are on?
See what the numbers say about this price, and find out in our valuation breakdown See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment looking split between concern and optimism, this is the moment to review the data for yourself and move quickly while others hesitate by weighing up the 2 key rewards and 4 important warning signs.
Looking for more investment ideas?
If this situation has sharpened your focus, do not stop here; broaden your watchlist with focused stock ideas that match the kind of portfolio you want to build.
- Target potential upside by scanning for companies that pair quality with lower valuations using our 51 high quality undervalued stocks
- Build income into your portfolio by reviewing stocks highlighted as potential 10 dividend fortresses
- Sleep easier at night by shortlisting companies identified through the 67 resilient stocks with low risk scores
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
